FORMA THERAPEUTICS HLDGS INC's ticker is FMTX and the CUSIP is 34633R104. A total of 60 filers reported holding FORMA THERAPEUTICS HLDGS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $181,000 | -33.5% | 9,057 | -77.1% | 0.00% | – |
| Q2 2022 | $272,000 | -98.1% | 39,471 | -97.4% | 0.00% | -100.0% |
| Q1 2022 | $14,173,000 | -74.3% | 1,524,063 | -60.7% | 0.00% | -75.0% |
| Q4 2021 | $55,131,000 | -53.1% | 3,877,053 | -23.6% | 0.00% | -55.6% |
| Q3 2021 | $117,649,000 | -18.9% | 5,073,300 | -12.9% | 0.01% | -18.2% |
| Q2 2021 | $145,055,000 | +4.2% | 5,827,864 | +17.3% | 0.01% | -8.3% |
| Q1 2021 | $139,259,000 | -3.0% | 4,969,969 | +20.8% | 0.01% | -7.7% |
| Q4 2020 | $143,636,000 | +59.0% | 4,115,649 | +127.0% | 0.01% | +44.4% |
| Q3 2020 | $90,352,000 | +9.0% | 1,812,828 | +1.7% | 0.01% | 0.0% |
| Q2 2020 | $82,904,000 | – | 1,783,287 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 1,565,529 | $43,866,000 | 8.09% |
| Logos Global Management LP | 1,410,000 | $39,508,000 | 3.86% |
| RA Capital Management | 9,011,651 | $252,506,000 | 3.81% |
| Cormorant Asset Management, LP | 4,720,000 | $132,254,000 | 2.95% |
| Artal Group S.A. | 1,000,000 | $28,020,000 | 0.50% |
| Perceptive Advisors | 1,250,000 | $35,025,000 | 0.44% |
| HighVista Strategies LLC | 20,630 | $578,000 | 0.43% |
| HHLR ADVISORS, LTD. | 1,100,000 | $30,822,000 | 0.30% |
| Baker Brothers Advisors | 2,024,876 | $56,737,000 | 0.25% |
| Tekla Capital Management LLC | 149,825 | $4,198,000 | 0.14% |